Crossmark

Physiologic colonic uptake of 18F-FDG on PET/CT is associated with clinical response and gut microbiome composition in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors

Crossref DOI link: https://doi.org/10.1007/s00259-020-05081-6

Published Online: 2020-10-31

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cvetkovic, Lena

Régis, Claudine

Richard, Corentin

Derosa, Lisa

Leblond, Antoine

Malo, Julie

Messaoudene, Meriem

Desilets, Antoine

Belkaid, Wiam

Elkrief, Arielle

Routy, Bertrand

Juneau, Daniel
License Information

Text and Data Mining valid from 2020-10-31

Version of Record valid from 2020-10-31
More Information

Article History

Received: 15 August 2020

Accepted: 15 October 2020

First Online: 31 October 2020

Compliance with ethical standards

:

: DJ has received consultant fees from AbbVie and Advanced Accelerator Applications. BR reports acting as a Scientific Advisory Board Member for Vedanta. All other authors have no disclosures.

: The study protocol was approved by the Ethics Committee (Ethics number CER CHUM: 18.039 and 18.085-17.035) and conducted in accordance with the tenets of the Declaration of Helsinki. The need for informed patient consent was waived.

Document is current

Any future updates will be listed below